• Aug 20, 2025Indian CDMOs, CRDMOs gain from supply chain shift | American Injectables expands Florida facility
    Aug 19, 2025WuXi AppTec invests in new modalities | WuXi Biologics Ireland facility gets EMA approval
    Aug 16, 2025Chemicals not part of Trump supply chain strategy | ProBio launches cGMP AAV manufacturing
    Aug 15, 2025Trump order boosts US drug API stockpile | WuXi automated continuous drug substance platform
    Aug 14, 2025Life sciences-pharma's Q2 robotics buying spree | AbbVie to build $195M API plant in Illinois
    Aug 13, 2025FDA’s PreCheck program lacks details | Sartorius partners on immune cell manufacturing
    Aug 12, 2025Lifecore leverages fill-finish capacity, targets growth | Lonza partners to improve CGT manufacturing
    Aug 9, 2025Trump, The Art of the Deal, and pharma tariffs | India-based Garonit to build plant in NY
    Aug 8, 2025NJ’s life sciences hub remains hot | FDA program seeks boost in US drug manufacturing
    Aug 7, 2025Trump threatens 250% tariff on pharma | Stevanato raises forecast as new facilities gain scale
    Aug 6, 2025Eli Lilly to sell New Jersey manufacturing plant | Axplora expands API capacity in India
    Aug 5, 2025Regeneron hit with CRL following FDA inspection | Almac Group expands US site
    Aug 2, 2025GlobalData: trade deal puts pharma industry at risk | Esteve expands into US
    Aug 1, 2025Tariffs prompt Celltrion to buy US biologics plant | Sandoz to acquire Evotec's facility in France
    Jul 31, 2025Merck looks to optimize manufacturing in restructuring | Phlow, Antheia team to bolster US supply chains
    Jul 30, 2025US-EU trade deal gets mixed reviews from analysts | Asahi Kasei to build fourth spinning plant
    Jul 29, 2025US, EU agree to trade deal but pharma questions remain | Simtra buys Indiana site to expand injectable capacity
    Jul 26, 2025AstraZeneca, Biogen, Thermo Fisher jump on US investment bandwagon | Samsung Biologics continues revenue upswing
    Jul 25, 2025Thermo Fisher boosts US fill-finish capacity with Sanofi deal | Stevanato secures more than $200M in financing
    Jul 24, 2025Lonza's CDMO revenue exceeds expectations | Coriolis Pharma to open $10M R&D lab
    Jul 23, 2025AstraZeneca pledges $50B in US operations amid tariff threat | Biogen to invest $2B in North Carolina plant expansion
    Jul 22, 2025Moderna nixes plan for Japan manufacturing plant | WuXi Biologics clears FDA inspections at China facilities
    Jul 19, 2025PCI’s $10B valuation is good news for CDMO sector | GenesisM breaks ground on biomanufacturing facility
    Jul 18, 2025J&J credits new tax law for enabling its $55B US investment | Bora expands tube-filling capacity at Canadian site
    Jul 17, 2025Thermo Fisher to acquire Sanofi's US sterile drug site | Amphastar to quadruple capacity at California headquarters
    Latest Edition